Ibotta director Bryan Leach proposes $4.71M sale
The proposed sale is connected to a selling plan dated March 5, 2026, intended to comply with Rule 10b5-1(c); the shares were acquired upon option exercise on June 8, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ibotta, Inc. (IBTA) is the issuer named in a notice covering Bryan Leach, an officer and director, and a proposed sale of 97,853 Class A common shares with an aggregate market value of $4,709,664.89.
The issuer had 20,148,602 shares outstanding as of October 20, 2026. The notice also lists prior three-month Class A sales by Bryan Leach and the Orion 2024 GST Trust and Elysian 2024 GST Trust.
Key Figures
Key Terms
Rule 10b5-1(c) regulatory
option exercise financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was Bryan Leach's proposed IBTA sale connected to a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.